Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • News

AstraZeneca Expands Gene Therapy Pipeline with JCR Deal Worth Up to $825M

  • The Pharma Data
  • July 10, 2025

AstraZeneca’s Alexion Taps JCR Pharmaceuticals for Gene Therapy Capsids in Deal Worth Up to $825M AstraZeneca’s rare disease unit, Alexion, is deepening its partnership with Japan-based JCR Pharmaceuticals through a…

Read MoreAstraZeneca Expands Gene Therapy Pipeline with JCR Deal Worth Up to $825M
  • NewsTechnology

Nuclidium Secures $99M Series B to Develop Copper-Based Radiopharma Technology

  • The Pharma Data
  • July 10, 2025

Nuclidium Secures $99M Series B to Advance Copper-Based Radiopharma Platform Swiss biotech Nuclidium has raised approximately $99 million in a Series B funding round to accelerate the development of its…

Read MoreNuclidium Secures $99M Series B to Develop Copper-Based Radiopharma Technology
  • Business

Merck to Acquire Verona Pharma, Adding Ohtuvayre to Bolster COPD Portfolio

  • The Pharma Data
  • July 10, 2025

Merck to Acquire Verona Pharma in $10 Billion Deal, Adding Ohtuvayre® to Strengthen Respiratory Portfolio and Expand Long-Term Growth in COPD Market Merck & Co., known as MSD outside the…

Read MoreMerck to Acquire Verona Pharma, Adding Ohtuvayre to Bolster COPD Portfolio
  • Regulatory

Lilly’s Kisunla Gets FDA Nod for Updated Label and Dosing in Early Alzheimer’s

  • The Pharma Data
  • July 10, 2025

FDA Greenlights Label Update and Revised Dosing Schedule for Lilly’s Kisunla (donanemab‑azbt) in Early Symptomatic Alzheimer’s Eli Lilly and Company today announced that the U.S. Food and Drug Administration (FDA)…

Read MoreLilly’s Kisunla Gets FDA Nod for Updated Label and Dosing in Early Alzheimer’s
  • Research

ICON Team Earns Recognition for Leadership and Sustainable Innovation

  • The Pharma Data
  • July 8, 2025

ICON Celebrated for Clinical Research Leadership, Innovation, and Sustainability in 2025 a global leader in healthcare intelligence and clinical research, has received widespread industry recognition during the first half of…

Read MoreICON Team Earns Recognition for Leadership and Sustainable Innovation
  • Press Releases

Glass Lewis Backs Sinovac’s Current Board

  • The Pharma Data
  • July 7, 2025

Glass Lewis Endorses Sinovac’s Current Board, Urges Shareholders to Reject Former Directors’ Takeover Attempt Sinovac Biotech Ltd., a leading Chinese biopharmaceutical company, announced today that Glass Lewis, a top independent…

Read MoreGlass Lewis Backs Sinovac’s Current Board
  • Press Releases

ISS Recommends Sinovac Shareholders Support Current Board

  • The Pharma Data
  • July 7, 2025

ISS and Glass Lewis Endorse Sinovac’s Current Board Ahead of Crucial Shareholder Vote Sinovac Biotech Ltd. a leading Chinese biopharmaceutical company, announced that Institutional Shareholder Services Inc. (ISS), one of…

Read MoreISS Recommends Sinovac Shareholders Support Current Board
  • RegulatoryPress Releases

Sickle Cell Disease Treatment Market Outlook 2025–2035: R&D, Patents, Pipeline & Regulations

  • The Pharma Data
  • July 5, 2025

Global Sickle Cell Disease Treatment Market Poised for Robust Growth Through 2035 The global sickle cell disease (SCD) treatment market is set to witness substantial growth from 2025 to 2035,…

Read MoreSickle Cell Disease Treatment Market Outlook 2025–2035: R&D, Patents, Pipeline & Regulations
  • Press Releases

Cancer Vaccine Market 2021–2031: Growth Driven by Innovation & Precision Immunotherapy

  • The Pharma Data
  • July 5, 2025

Global Cancer Vaccine Market Poised for Strong Growth Through 2031, Driven by Innovation in Precision Immunotherapy and Personalized Medicine The global cancer vaccine market has experienced robust growth over recent…

Read MoreCancer Vaccine Market 2021–2031: Growth Driven by Innovation & Precision Immunotherapy
  • Press Releases

Pharma & Biotech Distribution Deals Report 2025: Company A–Z Directory & Trends

  • The Pharma Data
  • July 5, 2025

In-Depth Report Sheds Light on Distribution Deals in the Pharma and Biotech Sectors (2020–2025) A newly updated research publication, Distribution Deals in Pharmaceuticals and Biotechnology, offers a comprehensive analysis of…

Read MorePharma & Biotech Distribution Deals Report 2025: Company A–Z Directory & Trends
  • Business

Pharma & Biotech Manufacturing Agreement Trends 2020–2025

  • The Pharma Data
  • July 5, 2025

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology (2020–2025): An In-Depth Analysis of Industry Trends, Financials, and Strategic Partnerships new industry report titled “Manufacturing and Supply Deals in Pharmaceuticals and…

Read MorePharma & Biotech Manufacturing Agreement Trends 2020–2025
  • BusinessNews

WHO Welcomes IMF Support for Jordan’s Pandemic Preparedness

  • The Pharma Data
  • July 5, 2025

WHO Applauds IMF’s Landmark $700 Million Support to Jordan for Pandemic Preparedness and Response The World Health Organization (WHO) has lauded a groundbreaking decision by the International Monetary Fund (IMF)…

Read MoreWHO Welcomes IMF Support for Jordan’s Pandemic Preparedness
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Synthetic Design Lab Debuts First Logic-Gated ADC at AACR 2026, Delivering ≥10X Enhanced Targeted Cancer Cell Killing
  • Lundbeck Showcases Real-World Improvements in Migraine-Related Cognitive Symptoms with VYEPTI® at AAN 2026
  • Zai Lab Highlights Preclinical Data Showing ZL-1503 Delivers Rapid Itch Relief and Anti-Inflammatory Effects in Atopic Diseases
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.